FDA issues bismacine-chromacine warning

Jul 24, 2006

The U.S. Food and Drug Administration is warning consumers and healthcare providers not to use a product called bismacine, also known as chromacine.

The FDA says it is investigating one report of a death and several reports of injury related to the administration of bismacine -- an injectable product that has been used to treat Lyme disease.

FDA officials said bismacine, which is not approved for anything, including Lyme disease, is not a pharmaceutical and is mixed individually by druggists. It is prescribed or administered by doctors of "alternative health" or by people claiming to be medical doctors.

The product contains high amounts of bismuth, a heavy metal that is used in some medications to treat Helicobacter pylori, a bacteria that can cause stomach ulcers but that is not approved in any form for use by injection.

Copyright 2006 by United Press International

Explore further: Will the Affordable Care Act eliminate health disparities?

Related Stories

Future US Navy: Robotic sub-hunters, deepsea pods

2 hours ago

The robotic revolution that transformed warfare in the skies will soon extend to the deep sea, with underwater spy "satellites," drone-launching pods on the ocean floor and unmanned ships hunting submarines.

Europe resumes Galileo satnav deployment (Update)

14 hours ago

Europe resumed deployment of its beleaguered Galileo satnav programme on Friday, launching a pair of satellites seven months after a rocket malfunction sent two multi-million euro orbiters awry.

Italian olive tree disease stumps EU

14 hours ago

EU member states are divided on how to stop the spread of a disease affecting olive trees in Italy that could result in around a million being cut down, officials said Friday.

Festo has BionicANTs communicating by the rules for tasks

14 hours ago

Germany-based automation company Festo, focused on technologies for tasks, turns to nature for inspiration, trying to take the cues from how nature performs tasks so efficiently. "Whether it's energy efficiency, ...

Recommended for you

Will the Affordable Care Act eliminate health disparities?

42 minutes ago

Massachusetts' health reform may be a crystal ball for researchers and policymakers in forecasting the potential impact of the Affordable Care Act. Many see the ACA as the backbone of efforts toward closing the nation's health ...

Japan's Takeda offers $2.2 bn to settle US drug lawsuits

2 hours ago

Japan's top drugmaker Takeda Pharmaceutical has offered $2.2 billion to settle US claims linked to its diabetes drug Actos, in what would be one of the biggest US payouts over patient lawsuits, a report said Wednesday.

Blood test predicts severity of peanut and seafood allergies

6 hours ago

A new blood test promises to predict which people will have severe allergic reactions to foods according to a new study led by Mount Sinai researchers and published online today in the The Annals of Allergy, Asthma & Immunology.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.